In cancer, chronic stimulation induces TIM3 upregulation in tumor antigen-specific T lymphocytes, especially in CD8+ TILs, and, at the same time, peripheral T cells show minimal TIM3 expression. This evidence concerns the gene HAVCR2 and neoplasm.